What is the translation of " ENTEROCOCCUS " in English?

• enterococcus

Examples of using Enterococcus in Slovenian and their translations into English

Inherentno rezistentni mikroorganizmi Grampozitivni aerobi Enterococcus spp.
Inherently resistant organisms Gram-positive aerobes Enterococcus spp.

Enterococcus faecium- bakterije, ki redno naseljujejo prebavila.
Enterococcus faecium- bacteria that routinely populate the gastrointestinal tract.

Toda zdravilo"Bifiform" vključuje v svoji sestavi tudi Enterococcus faecium.
But the drug"Bifiform" includes in its composition also Enterococcus faecium.

Enterokoki, vključno z Enterococcus faecalis in Enterococcus faecium.
Enterococci including Enterococcus faecalis and Enterococcus faecium.

Vsebujejo žive bakterije mlečne kisline dveh vrst- Bifidobacterium longum in Enterococcus faecium.
They contain live lactic acid bacteria of 2 species- Bifidobacterium longum and Enterococcus faecium.

Pseudomonas spp., Enterococcus spp, in Bordetella bronchiseptica izolati so že naravno rezistentni na cefovecin.
Pseudomonas spp., Enterococcus spp, and Bordetella bronchiseptica isolates are inherently resistant to cefovecin.

Druga probiotični sev treba raje več alkalnih in anaerobnih pogojih debelega črevesa- v entiro ™ znan kot Enterococcus mundtii(ST4France).
The other probiotic strain should prefer the more alkaline and anaerobic conditions of the large intestine- in entiro™ known as Enterococcus mundtii(ST4SA).

Multirezistentna Enterococcus faecalis in Enterococcus faecium povezujejo z nosokomialnimi okužbami.
Multidrug-resistant Enterococcus faecalis and Enterococcus faecium are associated with nosocomial infections.

Učinkovito proti gram-pozitivnim in gram-negativnim bakterijam, vključno s Staphylococcus spp., Enterococcus spp., Pseudomonas aeruginosa, E. coli, Streptococcus spp.
Effective against gram-positive and gram-negative bacteria, including Staphylococcus spp., Enterococcus spp., Pseudomonas aeruginosa, E. coli, Streptococcus spp.

Vsebuje bakterijo Enterococcus faecium, ki ima lahko kompleksen regeneracijski učinek na črevesno mikrofloro.
It contains the bacterium Enterococcus faecium, which can have a complex regenerating effect on the intestinal microflora.

Ena kapsula vsebuje v svoji sestavi žive bakterije mlečne kisline dveh vrst- Bifidobacterium longum(10 7 bakterijskih celic) in Enterococcus faecium(10 7 bakterijskih celic).
One capsule contains in its composition live lactic acid bacteria of 2 species- Bifidobacterium longum(10 7 bacterial cells) and Enterococcus faecium(10 7 bacterial cells).

Vancomycin-resistant enterococcus so bakterije iz rodu enterokokov, ki so odporne proti antibiotiku vankomicinu.
Vancomycin-resistant Enterococcus, or vancomycin-resistant enterococci(VRE), are bacterial strains of the genus Enterococcus that are resistant to the antibiotic vancomycin.

Elegans so označeni kot gostitelj za več človeških patogenih bakterijskih vrst(npr. Staphylococcus aureus in Enterococcus faecalis), ki jih je mogoče enostavno kultivirani, vzdrževati in razvijal.
Elegans has been characterized as a host for multiple human pathogenic bacteria species(i.e., Staphylococcus aureus and Enterococcus faecalis), which can be easily cultured, maintained, and evolved.

Bacteroides, Enterococcus, Escherichia colie, Klebsiella stafilokokni ali Streptococcus so najpogostejše vrste bakterij, ki povzročajo tovrstne okužbe.
Bacteroides, enterococcus, escherichia colie, klebsiella staphylococcus or streptococcus are the most common kinds of bacteria that cause this type of infection.

Proti vankomicinu odporni enterokoki(kratica VRE, angl. Vancomycin-resistant enterococcus) so bakterije iz rodu enterokokov, ki so odporne proti antibiotiku vankomicinu.
Vancomycin-resistant Enterococcus, or vancomycin-resistant enterococci(VRE), are bacterial strains of the genus Enterococcus that are resistant to the antibiotic vancomycin.

Ocena Enterococcus faecium NCIMB 10415 je pokazala, da so pogoji za dovoljenje iz člena 5 Uredbe(ES) št. 1831/2003 izpolnjeni.
The assessment of the preparation of Enterococcus faecium DSM 10663/NCIMB 10415 shows that the conditions for authorisation, as provided for in Article 5 of Regulation(EC) No 1831/2003, are satisfied.

V koncentraciji, ki je bila štirikrat višja od minimalne inhibicijske koncentracije(MIC), so s tigeciklinom opazovali zmanjšanje 2- log števila kolonij proti Enterococcus spp., Staphylococcus aureus in Escherichia coli.
At 4 times the minimum inhibitory concentration(MIC), a 2-log reduction in colony counts was observed with tigecycline against Enterococcus spp., Staphylococcus aureus, and Escherichia coli.

Odpornost na dalbavancin pri Staphylococcus spp. in Enterococcus spp. je posredovana z VanA, genotipom, ki povzroči spremembo ciljnega peptida v nastajajoči celični steni.
Resistance to dalbavancin in Staphylococcus spp. and Enterococcus spp. is mediated by VanA, a genotype that results in modification of the target peptide in nascent cell wall.

Za sklepanje o morebitni klinični učinkovitosti zdravila Cubicin pri zdravljenju okužb z enterokoki, vključno z bakterijama Enterococcus faecalis in Enterococcus faecium, ni dovolj dokazov.
There is insufficient evidence to be able to draw any conclusions regarding the possible clinical efficacy of Cubicin against infections due to enterococci, including Enterococcus faecalis and Enterococcus faecium.

Pomemben uvod Eksponent novega rodu enterokokov, Enterococcus faecalis je gram pozitivna bakterija, ki običajno naseljuje prebavila mnogih moških in drugih sesalcev.
Important introduction Exponent of the new genus of enterococci, Enterococcus faecalis is a gram positive bacterium that usually populates the gastrointestinal tract of many men and other mammals.

Zdravilo ima dober baktericidni učinek, ki je uporaben za večino gram pozitivnih(enterococcus, staphylococcus) in gram-negativnih(citobakterij, enterovirusov, klebsiel, morganel, proteus, pseudomonas) patogenov.
The drug has a good bactericidal effect, which is applicable to most gram-positive(enterococcus, staphylococcus) and gram-negative(cytobacteria, enterovirus, klebsiella, morganella, proteus, pseudomonas) pathogens.

Vloga zadeva dovoljenje za novo uporabo pripravka Enterococcus faecium DSM 7134(Bonvital) kot krmnega dodatka za svinje in njegovo uvrstitev v kategorijo dodatkov„zootehnični dodatki“.
The application concerns authorisation of a new use of the preparation of Enterococcus faecium DSM 7134(Bonvital), as a feed additive for piglets(weaned) and pigs for fattening, to be classified in the additive category‘zootechnical additives'.

O neuspehu zdravljenja so poročali predvsem pri bolnikih, ki so bili okuženi s Staphylococcus aureus, z Enterococcus faecalis ali z Enterococcus faecium, med drugim pri bolnikih, ki so imeli med zdravljenjem bakteriemijo v.
In particular, there have been reports of treatment failures in patients infected with Staphylococcus aureus, Enterococcus faecalis or Enterococcus faecium, including bacteraemic patients, that have been associated with the selection of organisms with reduced susceptibility or frank resistance to daptomycin during therapy.

O neuspehu zdravljenja so poročali predvsem pri bolnikih, ki so bili okuženi s Staphylococcus aureus, z Enterococcus faecalis ali z Enterococcus faecium, med drugim pri bolnikih, ki so imeli med zdravljenjem bakteriemijo v povezavi z določenimi mikroorganizmi, ki so postali manj občutljivi za daptomicin ali so bili rezistentni nanj.
In particular, there have been reports of treatment failures in patients infected with Staphylococcus aureus, Enterococcus faecalis or Enterococcus faecium, including bacteraemic patients, that have been associated with the selection of organisms with reduced susceptibility or frank resistance to daptomycin during therapy.

Drugi mikroorganizmi Chlamydia trachomatis($) Chlamydia pneumoniae($) Mycoplasma hominis($) Mycoplasma pneumoniae($) VRSTE, PRI KATERIH JE PRIDOBLJENA ODPORNOST LAHKO DVOMLJIVA aerobni, po Gramu pozitivni mikroorganizmi Enterococcus faecalis($) Staphylococcus spp.*(2) aerobni, po Gramu negativni mikroorganizmi Acinetobacter baumannii+ Burkholderia cepacia+* Campylobacter spp.+* Citrobacter freundii* Enterobacter aerogenes Enterobacter cloacae* Escherichia coli* Klebsiella oxytoca Klebsiella pneumoniae* Morganella morganii* Neisseria gonorrhoeae* Proteus mirabilis* Proteus vulgaris* Providencia spp.
Yersinia pestis Anaerobic micro-organisms Mobiluncus Other micro-organisms Chlamydia trachomatis($) Chlamydia pneumoniae($) Mycoplasma hominis($) Mycoplasma pneumoniae($) SPECIES FOR WHICH ACQUIRED RESISTANCE MAY BE A PROBLEM Aerobic Gram-positive micro-organisms Enterococcus faecalis($) Staphylococcus spp.*(2) Aerobic Gram-negative micro-organisms Acinetobacter baumannii+ Burkholderia cepacia+* Campylobacter spp.+* Citrobacter freundii* Enterobacter aerogenes Enterobacter cloacae* Escherichia coli* Klebsiella oxytoca Klebsiella pneumoniae* Morganella morganii* Neisseria gonorrhoeae* Proteus mirabilis* Proteus vulgaris* Providencia spp.

Linezolid je učinkovit proti vsem klinično pomembnim grampozitivnim bakterijam(le-te so obdane z debelim peptidoglikanskim slojem in so brez zunanje membrane), tudi proti Enterococcus faecium in Enterococcus faecalis(vključno s proti vankomicinu odpornimi enterokoki), Staphylococcus aureus(vključno s proti meticilinu odpornim Staphylococcus aureus, MRSA), Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, alfahemolitičnim streptokokom, Listeria monocytogenes in korinebakterijam(slednje so med najobčutljivejšimi na linezolid z minimalno inhibitorno koncentracijo manj kot 0,5 mg/L).
Linezolid is effective against all clinically important Gram-positive bacteria- those whose cell wall contains a thick layer of peptidoglycan and no outer membrane- notably Enterococcus faecium and Enterococcus faecalis(including vancomycin-resistant enterococci), Staphylococcus aureus(including methicillin-resistant Staphylococcus aureus, MRSA), Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, the viridans group streptococci, Listeria monocytogenes, and Corynebacterium species(the latter being among the most susceptible to linezolid, with minimum inhibitory concentrations routinely below 0.5 mg/L).